UPDATE: JMP Securities Initiates Coverage on Quest Diagnostics on Multiple Industry Headwinds

In a report published Wednesday, JMP Securities analyst J.T. Haresco initiated coverage on Quest Diagnostics (NYSE: DGX ) with a Market Perform rating. In the report, JMP Securities noted, “We are initiating coverage on Quest Diagnostics (DGX) with a Market Perform rating. DGX provides clinical laboratory services and offers access